Content Object
(
    [className] => Content
    [contentLinks] => Array
        (
        )

    [belongsTo] => 
    [contentIssue] => 
    [id] => 310448
    [pageNumber] => 
    [offset] => 
    [totalPages] => 
    [last_query] => 
    [last_sql] => 
    [show_errors] => 1
    [databaseServer] => Array
        (
            [key] => master
            [host] => 172.24.16.232
            [user] => rodpub_beta
            [pass] => MvQQzhse92k58yA
            [db] => rodpub_beta
        )

    [tableName] => contents
    [content_type_id] => 2487
    [resource_id] => 0
    [author_id] => 0
    [primary_issue_slug] => 
    [author_name] => {"name":"Business Wire","title":""}
    [magazine_id] => 6
    [layout_id] => 0
    [primary_image] => 185357
    [primary_image_old] => 
    [slider_image_id] => 
    [banner_image] => 0
    [title] => Confluent Medical Technologies Launches Nitinol Tubing Center of Excellence
    [short_title] => 
    [summary] => Company acquires Tube Hollows International to provide wide selection of nitinol tubing for high-performance implants.
    [slug] => confluent-medical-technologies-launches-nitinol-tubing-center-of-excellence
    [body] => Confluent Medical (formerly Nitinol Devices & Components, “NDC”) has launched the High-Performance Nitinol Tubing Center of Excellence in response to increasing market demand for high-performance nitinol tubing in challenging applications such as transcatheter heart valves, neurovascular, electrophysiology, and interventional pulmonary. 
 
The High-Performance Nitinol Tubing Center of Excellence has internal capabilities that include:  
The acquisition of Tube Hollows International has been a key piece in the development of the High-Performance Nitinol Tubing Center of Excellence. THI is the leader in precision gun-drilling of nitinol tube hollows. Additionally, THI brings capabilities in centerless grinding and precision machining.
 
Confluent Medical’s High-Performance Nitinol Tubing Center of Excellence is ideally set up to support medical device companies that require world-class nitinol tubing for their designs for long-term implantable applications within the heart and other critical structures.
 
Confluent Medical Technologies is the largest contract manufacturer of specialized medical devices. Its portfolio of services includes nitinol components, biomedical textiles, balloon expandable stents and balloon catheters, delivery systems, access kits, and guidewires. With manufacturing facilities in Fremont, Calif.; Sunnyvale, Calif.; Laguna Niguel, Calif.; Warwick, R.I.; and San Jose, Costa Rica, Confluent Medical Technologies has a 20-year track record of partnering with the medical device community and delivering high-quality medical devices.  [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2019-03-21 09:13:00 [updated_at] => 2019-03-21 09:25:23 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["307683","304362","308055","264713","300702","114892","306383","306380","306382","299797","298767","309000","305703","304033","28371"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 [contentType] => ContentType Object ( [className] => ContentType [content] => Array ( ) [taxonomy] => Array ( ) [listURL] => [logoUrl] => https: [id] => 2487 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => content_types [tag] => breaking_news [short_tag] => breaking_news [class_name] => [display_view] => [list_view] => [slug] => breaking-news [box_view] => [ignore_flag] => 0 [image_id] => 0 [layout_id] => 0 [formattedTag] => Breaking News ) [viewURL] => /contents/view_breaking-news/2019-03-21/confluent-medical-technologies-launches-nitinol-tubing-center-of-excellence/ [relatedArticles] => Array ( [0] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 298767 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Business Wire","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 175099 [primary_image_old] => [slider_image_id] => 175099 [banner_image] => 0 [title] => CynergisTek and Asimily Partner to Provide Complete Connected Device Lifecycle Management [short_title] => [summary] => Healthcare IT vendors collaborate to address medical device security. [slug] => cynergistek-and-asimily-partner-to-provide-complete-connected-device-lifecycle-management [body] => CynergisTek, a leader in healthcare cybersecurity and information management, and Asimily, a solution for connected device lifecycle management in healthcare, have announced a partnership to provide a joint security assessment for medical devices. The joint offering will provide healthcare providers with the ability to identify all devices connected to the network and the relationship between those devices, the capability to discover any existing risks or anomalies in the network, ability to discover and prioritize devices and vulnerabilities, and recommendations for mitigation and program improvement.
 
CynergisTek will use Asimily’s platform to provide risk assessment services as well as provide an ongoing managed service to its customers. During CynergisTek’s assessment, healthcare providers can trial Asimily’s solution with the option to purchase a license for continued device monitoring. Once licensed, Asimily’s solution will provide additional elements to providers for complete medical device lifecycle management, including detailed asset utilization, the ability to track and discover devices not being used as expected, and the capability to block or segment devices on the network.

CynergisTek’s managed service will allow healthcare providers to identify and classify risks as well as determine appropriate technical remediation priorities on an ongoing basis. Together, CynergisTek and Asimily will help providers understand the number of biomedical devices connected to the network and the known risks and vulnerabilities to help customers develop a strategy to secure the devices going forward.
 
“Our customers now can not only get the most comprehensive medical device assessment and cybersecurity management platform in the market to support managing the complete biomedical device lifecycle, but also get the assessments, recommendations, remediation, and management support from an industry leader like CynergisTek,” said Shankar Somasundaram, co-founder and CEO of Asimily. “Our joint work with CynergisTek will provide customers with the best in class service and product offering that will significantly improve their ability to manage and secure their connected devices.”
 
“We are excited to form a partnership with Asimily to provide our customers with a holistic approach to device management, something the industry and patients have needed for a very long time,” said Mac McMillan, CEO of CynergisTek. “Together, our solution will help healthcare organizations address the challenge of not only managing medical devices more effectively, but will be able to secure the countless medical devices that are connected to the network and addressing the risks around medical devices from both a clinical operations and a patient care perspective.”
 
Asimily is a team with backgrounds in healthcare, security, machine learning and analytics. It has built and launched solutions for connected devices at startups to Fortune 500 companies. The company provides a solution to comprehensively monitor and manage devices through their entire life-cycle in the healthcare environment. This will allow different players in the ecosystem to focus on their core job of providing great healthcare. Asimily is headquartered in Sunnyvale, Calif.
 
CynergisTek is a top-ranked cybersecurity and information management consulting firm dedicated to serving the healthcare industry. CynergisTek offers specialized services and solutions to help organizations achieve privacy, security, compliance, and document output management goals. Since 2004, the company has served as a partner to hundreds of healthcare organizations and is dedicated to supporting and educating the industry by contributing to relevant industry associations. The company has been named in numerous research reports as one of the top firms that provider organizations turn to for privacy and security, and won the 2017 Best in KLAS award for Cyber Security Advisory Services. [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-09-24 09:23:00 [updated_at] => 2018-09-24 09:28:18 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["290022","289756","282689","289741","276287","279074","282671","282673","276270","296459","277504","280351","281907","296472","280159"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [1] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 299797 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2490 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => 2018-10-01 [author_name] => {"name":"Florence Joffroy-Black and Dave Sheppard","title":"MedWorld Advisors"} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 176257 [primary_image_old] => [slider_image_id] => 176257 [banner_image] => 0 [title] => Supply Chain 2020—How Are You Trending? [short_title] => [summary] => [slug] => supply-chain-2020-how-are-you-trending [body] => Since the dawn of the 21st century, prognosticators have been looking ahead to the year 2020 and predicting what life might be like for various industries, markets, and professions. As that target year quickly approaches (14 months out), it’s worth taking a look at key supply chain initiatives and how they are currently trending. 

Key 2020 topics have been extensively discussed, examined with vigor and intensity, and shared with supply chain professionals. Some of the more interesting predictions for the sector include:
Let’s examine these topics on an individual basis.

Supply Chain Professionals
As the 20th century faded into the new millennium, it was clear the occupation of the supply chain executive had forever changed from a tactical purchasing role to that of a strategic professional. That observation has never been more true than it is now, in 2018. The supply chain executive role has been elevated in most organizations, with strategic purchasing decisions in many cases significantly impacting corporate profitability. These decisions can help facilitate market entry or create obstacles in various geographies and/or industries. As a result, there has been an increase in educational programs (both inside and outside the academic setting) dedicated to supply chain management and the success of supply chain professionals.

Global Supply Chains
In the medtech industry, the idea of global supply chains sprouted from the need for lower-cost products due to increasing pricing pressure during the past 20 years. It began with the production of less expensive components such as circuit boards, widgets, and other items in lower-cost (oftentimes developing) countries. Today, however, the practice has evolved into a much broader spectrum.

Ability to Segment Regionally and Globally
The “spaghetti string” of the early global supply chains became problematic. What an organization saved in component cost was often counteracted by increases in logistical (i.e., shipping) expenses. Therefore, the benefits of the initial creation of global supply chains has allowed for continuous improvement through segmentation of the supply chain on a regional basis. Additionally, many companies have realized the importance of manufacturing closer to the customer. In Europe, this idea of “local-for-local manufacturing” has created an increase in Eastern European production to serve the European Union markets. Across the Atlantic, Puerto Rico, Costa Rica, and Mexico have driven cost efficiencies in the Americas through free trade zones, while China has reaped the biggest benefits of this trend in the Asian market. Considered merely a lower-cost component manufacturing country at the turn of the century, China is now a fully capable “finished device” manufacturer for the emerging markets. Companies are finally realizing the competitive advantage that comes with designing and manufacturing their products locally, for local sale.

External Supply Chain Transparency
The need for additional supply chain transparency in the medical technology industry has been driven by regulatory factors and social media/cultural pressures. The regulatory environment used to be far less complicated than it is today. Around the turn of the century, a company only needed to manage its own manufacturing processes from the time it received a supplier’s product (assuming it performed an incoming inspection, etc.). But that is no longer an acceptable practice. The U.S. Food and Drug Administration now requires device manufacturers to manage their supply chains the same way they manage their own internal processes. Consequently, medical manufacturers now require their supply chains to conform to requirements such as ISO 13485; standards like ISO 9001 are no longer enough for most OEMs.

Thanks to social media, large medical technology companies (J&J, Medtronic plc, Stryker Corp., Baxter, Boston Scientific, etc.) are now more visible (and exposed) to the public than ever before. This creates an opportunity for the consumer to expect—and in some cases, demand—that these major companies engage in social responsibility in their supply chain practices. While initially a “pain” for some of these companies, most organizations have now embraced this issue as an opportunity to differentiate themselves and create an additional value proposition for their end customers.

Sustainability
Although it used to be an aspirational topic for many companies, most organizations have constructively engaged in sustainability in recent years. In doing so, they have moved from sustainability as an aspiration to a core value. Thus, sustainability goals are now set—and even measured. An MPO Supply Chain column in October 2017 (“Sustainable Procurement—What is Your Target?”) identifies key medtech OEMs that are heavily investing (and measuring) their sustainability results. These companies include industry giants like Cardinal Health, Edwards Lifesciences, Varian Medical Systems, and 3M.

Cloud Impact on Supply Chain
There are numerous white papers and articles addressing the positive impact of the Cloud on supply chain management and performance. Many of these documents (largely, white papers and articles) are written (or supported) by Cloud vendors that benefit from such references. These documents, however, are “directionally correct.” The Cloud is a positive influence on supply chain management performance in key areas like global access and the removal of regional boundaries;  the capacity for worldwide scalability; the integration of multiple IT platforms (i.e., due to M&A many organizations do not have a unified IT platform throughout their various regions and/or business units); and the ability to increase analytical tools on a transparent basis for key executives throughout the organization.

AI as a Key Factor
Outside the medical technology industry, it’s clear that companies like Walmart, Target, and Amazon are utilizing artificial intelligence as predictive analytics for demand forecasting and warehouse management. Within the industry, companies like Deloitte and Optum are marketing solutions for OEMs to improve their performance. As this is a recent trend, we look forward to more future documentation of the results of these efforts. This is likely to be a trend far beyond 2020.

Robotics in the Supply Chain
Moving to a low-cost country used to give supply chain executives enough confidence to justify the decision based on the labor savings alone. However, these markets are now experiencing wage inflation and have assumed increased cost pressures (excluding the potential tariff issues, which is a separate topic to address). With this escalating employee cost metric and the need for improved productivity on a global basis, robotics is increasingly being utilized in both developed and emerging markets. As robotics becomes more commonplace, the technology will likely increase the potential value of manufacturing jobs worldwide.

Blockchain Technology
Trendy, trendy, trendy—just referencing “blockchain” is instantly topical and edgy. However, blockchain is yet to be proven as a viable efficient technology (outside of bitcoin and initial coin offerings). It certainly has potential to have a tremendous impact across industries and market segments. It will be interesting to witness some of the actual utilizations and impacts of blockchain technology in supply chain management and specifically in medtech supply chain efficiency.

Conclusion
Overall, the prognosticators have been fairly accurate with their predictions. Some of these trends have occurred quickly while others are taking time to develop. Clearly, there will be additional key “trendy” items to discuss as the year 2020 looms larger on the horizon. In the meantime, be flexible and stay abreast of the trends affecting the supply chain. The future will be here in no time. v


Florence Joffroy-Black, CM&AA, is a long-time marketing and M&A expert with significant experience in the medical technology industry, including working for multi-national corporations based in the United States, Germany, and Israel. She can be reached at florencejblack@medworldadvisors.com

Dave Sheppard is a former Fortune 500 MedTech executive and is now a principal at MedWorld Advisors. He can be reached at davesheppard@medworldadvisors.com  [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-10-16 13:52:33 [updated_at] => 2018-10-16 13:52:33 [last_updated_author] => 195666 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["279724","283689","289756","289798","299952","290022","289765","289745","279662","299790","289770","289744","285583"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [2] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 300702 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"PR Newswire","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 176622 [primary_image_old] => [slider_image_id] => [banner_image] => 0 [title] => Resonetics Acquires STI Laser Industries [short_title] => [summary] => Company adds supplier in Israel for laser cutting, nitinol processing and cleanroom assembly. [slug] => resonetics-acquires-sti-laser-industries [body] => Resonetics has acquired STI Laser Industries Ltd. (STI), based in Or Akiva, Israel, a supplier of laser processing, nitinol shape setting and electropolishing, and cleanroom assembly and packaging for the medical device industry. In addition to servicing the prolific startup community in Israel, STI has developed a global business with extensive customer relationships in the United States, Japan, China, and Korea. Since being founded in 1998 by President and CEO Tovy Sivan, STI has grown rapidly by identifying unmet customer needs and responding aggressively with customized solutions.
 
"Israel is recognized around the world as an important medical device center and we are very excited to gain access to these customers with STI. Tovy's entrepreneurial spirit and the strong management team he assembled have created an impressive business serving the structural heart, neurovascular and minimally invasive surgery markets. The acquisition also broadens Resonetics' nitinol processing capabilities, an important capability to serve our growing interventional business," said Tom Burns, president and CEO of Resonetics.

STI is doubling the size of its operations in Or Akiva, 40 minutes North of Tel Aviv. Building 2 is under construction and will open in early 2020 to increase the Israel operation to 60,000 square feet to accommodate the company's growth and new manufacturing capabilities.
 
"I am very proud of the position STI has built in the industry over the past 20 years," remarked Sivan. "By joining forces with Resonetics now, we can offer our customers a broader set of manufacturing capabilities with the resources necessary to support best-in-class prototyping and high-volume production options in Israel, the United States, Europe and Costa Rica. We are uniquely positioned to service a growing list of industry leaders and I look forward to continuing to build this business with Tom, Chip and the team at GTCR."
 
Founded in 1987, Resonetics is a pioneer in laser micro manufacturing and provides contract manufacturing services to the life sciences industry. The company designs, builds and services its own laser workstations to solve complex manufacturing challenges. Resonetics also offers thin-wall, stainless steel tubing, precious metal radiopaque marker bands and nitinol processing. With five Lightspeed Application Development Labs in strategic medtech clusters, Resonetics is built for speed and provides winning solutions that meet all technical, quality and economic requirements. The company is ISO 13485:2016 certified with facilities in the United States, Costa Rica, and Israel. Resonetics is owned by Regatta Medical, a portfolio company of GTCR.
 
Founded in 1980, GTCR is a private equity firm focused on investing in growth companies in the growth business services, technology, media and telecommunications, healthcare and financial services and technology industries. The Chicago, Ill.-based firm pioneered The Leaders Strategy: finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. Since its inception, GTCR has invested more than $15 billion in over 200 companies. Regatta Medical was formed in April 2017 as a partnership between Robert "Chip" Hance, Mark Weishaar, and GTCR. Regatta Medical's mission is to build a leading company in the medical device industry by acquiring outstanding medical device products and services businesses. [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-10-24 09:53:00 [updated_at] => 2018-10-24 10:02:13 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["299581","284133","279711","299795","289587","300443","296459","300468","281185","296460","299791","279722","28717"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [3] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 304033 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2539 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 0 [primary_image_old] => [slider_image_id] => [banner_image] => 0 [title] => Biomedical Engineering Society (BMES) Annual Meeting [short_title] => [summary] => [slug] => biomedical-engineering-society-bmes-annual-meeting [body] => [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-12-10 15:27:00 [updated_at] => 2018-12-10 15:30:03 [last_updated_author] => 199474 [uploaded_by] => 199474 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["304030","303849","303823","302856","303127","303895","302847","302931","303126","300944","298767","28371","303288","296472","289752"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [4] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 304362 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Business Wire","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 179653 [primary_image_old] => [slider_image_id] => [banner_image] => 0 [title] => Intact Vascular Hires Industry Veteran as Vice President of Sales [short_title] => [summary] => Prior to joining Intact Vascular, new hire was the vice president of U.S. sales for Neuronetics. [slug] => intact-vascular-hires-industry-veteran-as-vice-president-of-sales [body] => Intact Vascular Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, announced that Steve MacKinnon has joined its senior management team as vice president of Sales, effective immediately. Reporting to the CEO, MacKinnon will oversee the creation of a U.S. based sales team and will play a central role in planning and executing the company’s projected launch of the Tack Endovascular System in 2019.
 
“Steve brings a stellar track record of sales achievement across a broad range of entrepreneurial medical technology companies,” said Bruce Shook, Intact Vascular’s president and CEO. “Steve’s experience with creating and motivating high performance sales teams, coupled with his deep knowledge of the peripheral vascular market, will be tremendous assets to us as we move toward launch of our flagship product next year.”
 
Prior to joining Intact Vascular, MacKinnon was the vice president of U.S. Sales for Neuronetics, where he significantly expanded the sales team and product revenue, and helped take the company public. Prior to Neuronetics, Steve served as vice president of U.S. Sales for Access Closure and was instrumental in its successful merger with Cardinal Health. He also held multiple sales positions with Fox Hollow Technologies prior to its sale to eV3.
 
“Intact Vascular represents an exciting opportunity to bring high-value innovations to peripheral vascular patients,” said Steve MacKinnon. “I look forward to building a world class sales organization at Intact and to a very successful launch of the Tack Endovascular System.”
 
Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack Endovascular System is designed to improve peripheral balloon angioplasty results in the treatment of peripheral arterial disease. Pre-loaded with six self-expanding nitinol devices for above-the-knee (ATK) interventions, the Tack Endovascular System can be deployed to treat multiple dissections using a single catheter and leaving behind less than 70 percent less metal than stents.1 Additionally, the Tack Endovascular System offers low radial force, designed to promote healing, improve outcomes and preserve future treatment options for PAD and critical limb ischemia (CLI) patients.
 
References
1. Bosiers M, Scheinert D, Hendricks JMH et al. Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplasty. J Vasc Surg 2016;64:109-16. [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-12-17 08:58:00 [updated_at] => 2018-12-17 09:11:31 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["303180","289765","289756","290022","289745","289790","289757","302111","299797","301733","289746","300701","299793","297829","289796","299952","289761","302321"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) ) [relatedContent] => Array ( [0] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 298767 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Business Wire","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 175099 [primary_image_old] => [slider_image_id] => 175099 [banner_image] => 0 [title] => CynergisTek and Asimily Partner to Provide Complete Connected Device Lifecycle Management [short_title] => [summary] => Healthcare IT vendors collaborate to address medical device security. [slug] => cynergistek-and-asimily-partner-to-provide-complete-connected-device-lifecycle-management [body] => CynergisTek, a leader in healthcare cybersecurity and information management, and Asimily, a solution for connected device lifecycle management in healthcare, have announced a partnership to provide a joint security assessment for medical devices. The joint offering will provide healthcare providers with the ability to identify all devices connected to the network and the relationship between those devices, the capability to discover any existing risks or anomalies in the network, ability to discover and prioritize devices and vulnerabilities, and recommendations for mitigation and program improvement.
 
CynergisTek will use Asimily’s platform to provide risk assessment services as well as provide an ongoing managed service to its customers. During CynergisTek’s assessment, healthcare providers can trial Asimily’s solution with the option to purchase a license for continued device monitoring. Once licensed, Asimily’s solution will provide additional elements to providers for complete medical device lifecycle management, including detailed asset utilization, the ability to track and discover devices not being used as expected, and the capability to block or segment devices on the network.

CynergisTek’s managed service will allow healthcare providers to identify and classify risks as well as determine appropriate technical remediation priorities on an ongoing basis. Together, CynergisTek and Asimily will help providers understand the number of biomedical devices connected to the network and the known risks and vulnerabilities to help customers develop a strategy to secure the devices going forward.
 
“Our customers now can not only get the most comprehensive medical device assessment and cybersecurity management platform in the market to support managing the complete biomedical device lifecycle, but also get the assessments, recommendations, remediation, and management support from an industry leader like CynergisTek,” said Shankar Somasundaram, co-founder and CEO of Asimily. “Our joint work with CynergisTek will provide customers with the best in class service and product offering that will significantly improve their ability to manage and secure their connected devices.”
 
“We are excited to form a partnership with Asimily to provide our customers with a holistic approach to device management, something the industry and patients have needed for a very long time,” said Mac McMillan, CEO of CynergisTek. “Together, our solution will help healthcare organizations address the challenge of not only managing medical devices more effectively, but will be able to secure the countless medical devices that are connected to the network and addressing the risks around medical devices from both a clinical operations and a patient care perspective.”
 
Asimily is a team with backgrounds in healthcare, security, machine learning and analytics. It has built and launched solutions for connected devices at startups to Fortune 500 companies. The company provides a solution to comprehensively monitor and manage devices through their entire life-cycle in the healthcare environment. This will allow different players in the ecosystem to focus on their core job of providing great healthcare. Asimily is headquartered in Sunnyvale, Calif.
 
CynergisTek is a top-ranked cybersecurity and information management consulting firm dedicated to serving the healthcare industry. CynergisTek offers specialized services and solutions to help organizations achieve privacy, security, compliance, and document output management goals. Since 2004, the company has served as a partner to hundreds of healthcare organizations and is dedicated to supporting and educating the industry by contributing to relevant industry associations. The company has been named in numerous research reports as one of the top firms that provider organizations turn to for privacy and security, and won the 2017 Best in KLAS award for Cyber Security Advisory Services. [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-09-24 09:23:00 [updated_at] => 2018-09-24 09:28:18 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["290022","289756","282689","289741","276287","279074","282671","282673","276270","296459","277504","280351","281907","296472","280159"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [1] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 299797 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2490 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => 2018-10-01 [author_name] => {"name":"Florence Joffroy-Black and Dave Sheppard","title":"MedWorld Advisors"} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 176257 [primary_image_old] => [slider_image_id] => 176257 [banner_image] => 0 [title] => Supply Chain 2020—How Are You Trending? [short_title] => [summary] => [slug] => supply-chain-2020-how-are-you-trending [body] => Since the dawn of the 21st century, prognosticators have been looking ahead to the year 2020 and predicting what life might be like for various industries, markets, and professions. As that target year quickly approaches (14 months out), it’s worth taking a look at key supply chain initiatives and how they are currently trending. 

Key 2020 topics have been extensively discussed, examined with vigor and intensity, and shared with supply chain professionals. Some of the more interesting predictions for the sector include:
Let’s examine these topics on an individual basis.

Supply Chain Professionals
As the 20th century faded into the new millennium, it was clear the occupation of the supply chain executive had forever changed from a tactical purchasing role to that of a strategic professional. That observation has never been more true than it is now, in 2018. The supply chain executive role has been elevated in most organizations, with strategic purchasing decisions in many cases significantly impacting corporate profitability. These decisions can help facilitate market entry or create obstacles in various geographies and/or industries. As a result, there has been an increase in educational programs (both inside and outside the academic setting) dedicated to supply chain management and the success of supply chain professionals.

Global Supply Chains
In the medtech industry, the idea of global supply chains sprouted from the need for lower-cost products due to increasing pricing pressure during the past 20 years. It began with the production of less expensive components such as circuit boards, widgets, and other items in lower-cost (oftentimes developing) countries. Today, however, the practice has evolved into a much broader spectrum.

Ability to Segment Regionally and Globally
The “spaghetti string” of the early global supply chains became problematic. What an organization saved in component cost was often counteracted by increases in logistical (i.e., shipping) expenses. Therefore, the benefits of the initial creation of global supply chains has allowed for continuous improvement through segmentation of the supply chain on a regional basis. Additionally, many companies have realized the importance of manufacturing closer to the customer. In Europe, this idea of “local-for-local manufacturing” has created an increase in Eastern European production to serve the European Union markets. Across the Atlantic, Puerto Rico, Costa Rica, and Mexico have driven cost efficiencies in the Americas through free trade zones, while China has reaped the biggest benefits of this trend in the Asian market. Considered merely a lower-cost component manufacturing country at the turn of the century, China is now a fully capable “finished device” manufacturer for the emerging markets. Companies are finally realizing the competitive advantage that comes with designing and manufacturing their products locally, for local sale.

External Supply Chain Transparency
The need for additional supply chain transparency in the medical technology industry has been driven by regulatory factors and social media/cultural pressures. The regulatory environment used to be far less complicated than it is today. Around the turn of the century, a company only needed to manage its own manufacturing processes from the time it received a supplier’s product (assuming it performed an incoming inspection, etc.). But that is no longer an acceptable practice. The U.S. Food and Drug Administration now requires device manufacturers to manage their supply chains the same way they manage their own internal processes. Consequently, medical manufacturers now require their supply chains to conform to requirements such as ISO 13485; standards like ISO 9001 are no longer enough for most OEMs.

Thanks to social media, large medical technology companies (J&J, Medtronic plc, Stryker Corp., Baxter, Boston Scientific, etc.) are now more visible (and exposed) to the public than ever before. This creates an opportunity for the consumer to expect—and in some cases, demand—that these major companies engage in social responsibility in their supply chain practices. While initially a “pain” for some of these companies, most organizations have now embraced this issue as an opportunity to differentiate themselves and create an additional value proposition for their end customers.

Sustainability
Although it used to be an aspirational topic for many companies, most organizations have constructively engaged in sustainability in recent years. In doing so, they have moved from sustainability as an aspiration to a core value. Thus, sustainability goals are now set—and even measured. An MPO Supply Chain column in October 2017 (“Sustainable Procurement—What is Your Target?”) identifies key medtech OEMs that are heavily investing (and measuring) their sustainability results. These companies include industry giants like Cardinal Health, Edwards Lifesciences, Varian Medical Systems, and 3M.

Cloud Impact on Supply Chain
There are numerous white papers and articles addressing the positive impact of the Cloud on supply chain management and performance. Many of these documents (largely, white papers and articles) are written (or supported) by Cloud vendors that benefit from such references. These documents, however, are “directionally correct.” The Cloud is a positive influence on supply chain management performance in key areas like global access and the removal of regional boundaries;  the capacity for worldwide scalability; the integration of multiple IT platforms (i.e., due to M&A many organizations do not have a unified IT platform throughout their various regions and/or business units); and the ability to increase analytical tools on a transparent basis for key executives throughout the organization.

AI as a Key Factor
Outside the medical technology industry, it’s clear that companies like Walmart, Target, and Amazon are utilizing artificial intelligence as predictive analytics for demand forecasting and warehouse management. Within the industry, companies like Deloitte and Optum are marketing solutions for OEMs to improve their performance. As this is a recent trend, we look forward to more future documentation of the results of these efforts. This is likely to be a trend far beyond 2020.

Robotics in the Supply Chain
Moving to a low-cost country used to give supply chain executives enough confidence to justify the decision based on the labor savings alone. However, these markets are now experiencing wage inflation and have assumed increased cost pressures (excluding the potential tariff issues, which is a separate topic to address). With this escalating employee cost metric and the need for improved productivity on a global basis, robotics is increasingly being utilized in both developed and emerging markets. As robotics becomes more commonplace, the technology will likely increase the potential value of manufacturing jobs worldwide.

Blockchain Technology
Trendy, trendy, trendy—just referencing “blockchain” is instantly topical and edgy. However, blockchain is yet to be proven as a viable efficient technology (outside of bitcoin and initial coin offerings). It certainly has potential to have a tremendous impact across industries and market segments. It will be interesting to witness some of the actual utilizations and impacts of blockchain technology in supply chain management and specifically in medtech supply chain efficiency.

Conclusion
Overall, the prognosticators have been fairly accurate with their predictions. Some of these trends have occurred quickly while others are taking time to develop. Clearly, there will be additional key “trendy” items to discuss as the year 2020 looms larger on the horizon. In the meantime, be flexible and stay abreast of the trends affecting the supply chain. The future will be here in no time. v


Florence Joffroy-Black, CM&AA, is a long-time marketing and M&A expert with significant experience in the medical technology industry, including working for multi-national corporations based in the United States, Germany, and Israel. She can be reached at florencejblack@medworldadvisors.com

Dave Sheppard is a former Fortune 500 MedTech executive and is now a principal at MedWorld Advisors. He can be reached at davesheppard@medworldadvisors.com  [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-10-16 13:52:33 [updated_at] => 2018-10-16 13:52:33 [last_updated_author] => 195666 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["279724","283689","289756","289798","299952","290022","289765","289745","279662","299790","289770","289744","285583"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [2] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 300702 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"PR Newswire","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 176622 [primary_image_old] => [slider_image_id] => [banner_image] => 0 [title] => Resonetics Acquires STI Laser Industries [short_title] => [summary] => Company adds supplier in Israel for laser cutting, nitinol processing and cleanroom assembly. [slug] => resonetics-acquires-sti-laser-industries [body] => Resonetics has acquired STI Laser Industries Ltd. (STI), based in Or Akiva, Israel, a supplier of laser processing, nitinol shape setting and electropolishing, and cleanroom assembly and packaging for the medical device industry. In addition to servicing the prolific startup community in Israel, STI has developed a global business with extensive customer relationships in the United States, Japan, China, and Korea. Since being founded in 1998 by President and CEO Tovy Sivan, STI has grown rapidly by identifying unmet customer needs and responding aggressively with customized solutions.
 
"Israel is recognized around the world as an important medical device center and we are very excited to gain access to these customers with STI. Tovy's entrepreneurial spirit and the strong management team he assembled have created an impressive business serving the structural heart, neurovascular and minimally invasive surgery markets. The acquisition also broadens Resonetics' nitinol processing capabilities, an important capability to serve our growing interventional business," said Tom Burns, president and CEO of Resonetics.

STI is doubling the size of its operations in Or Akiva, 40 minutes North of Tel Aviv. Building 2 is under construction and will open in early 2020 to increase the Israel operation to 60,000 square feet to accommodate the company's growth and new manufacturing capabilities.
 
"I am very proud of the position STI has built in the industry over the past 20 years," remarked Sivan. "By joining forces with Resonetics now, we can offer our customers a broader set of manufacturing capabilities with the resources necessary to support best-in-class prototyping and high-volume production options in Israel, the United States, Europe and Costa Rica. We are uniquely positioned to service a growing list of industry leaders and I look forward to continuing to build this business with Tom, Chip and the team at GTCR."
 
Founded in 1987, Resonetics is a pioneer in laser micro manufacturing and provides contract manufacturing services to the life sciences industry. The company designs, builds and services its own laser workstations to solve complex manufacturing challenges. Resonetics also offers thin-wall, stainless steel tubing, precious metal radiopaque marker bands and nitinol processing. With five Lightspeed Application Development Labs in strategic medtech clusters, Resonetics is built for speed and provides winning solutions that meet all technical, quality and economic requirements. The company is ISO 13485:2016 certified with facilities in the United States, Costa Rica, and Israel. Resonetics is owned by Regatta Medical, a portfolio company of GTCR.
 
Founded in 1980, GTCR is a private equity firm focused on investing in growth companies in the growth business services, technology, media and telecommunications, healthcare and financial services and technology industries. The Chicago, Ill.-based firm pioneered The Leaders Strategy: finding and partnering with management leaders in core domains to identify, acquire and build market-leading companies through transformational acquisitions and organic growth. Since its inception, GTCR has invested more than $15 billion in over 200 companies. Regatta Medical was formed in April 2017 as a partnership between Robert "Chip" Hance, Mark Weishaar, and GTCR. Regatta Medical's mission is to build a leading company in the medical device industry by acquiring outstanding medical device products and services businesses. [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-10-24 09:53:00 [updated_at] => 2018-10-24 10:02:13 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["299581","284133","279711","299795","289587","300443","296459","300468","281185","296460","299791","279722","28717"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [3] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 304033 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2539 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 0 [primary_image_old] => [slider_image_id] => [banner_image] => 0 [title] => Biomedical Engineering Society (BMES) Annual Meeting [short_title] => [summary] => [slug] => biomedical-engineering-society-bmes-annual-meeting [body] => [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-12-10 15:27:00 [updated_at] => 2018-12-10 15:30:03 [last_updated_author] => 199474 [uploaded_by] => 199474 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["304030","303849","303823","302856","303127","303895","302847","302931","303126","300944","298767","28371","303288","296472","289752"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) [4] => Content Object ( [className] => Content [contentLinks] => Array ( ) [belongsTo] => [contentIssue] => [id] => 304362 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => contents [content_type_id] => 2487 [resource_id] => 0 [author_id] => 0 [primary_issue_slug] => [author_name] => {"name":"Business Wire","title":""} [magazine_id] => 6 [layout_id] => 0 [primary_image] => 179653 [primary_image_old] => [slider_image_id] => [banner_image] => 0 [title] => Intact Vascular Hires Industry Veteran as Vice President of Sales [short_title] => [summary] => Prior to joining Intact Vascular, new hire was the vice president of U.S. sales for Neuronetics. [slug] => intact-vascular-hires-industry-veteran-as-vice-president-of-sales [body] => Intact Vascular Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, announced that Steve MacKinnon has joined its senior management team as vice president of Sales, effective immediately. Reporting to the CEO, MacKinnon will oversee the creation of a U.S. based sales team and will play a central role in planning and executing the company’s projected launch of the Tack Endovascular System in 2019.
 
“Steve brings a stellar track record of sales achievement across a broad range of entrepreneurial medical technology companies,” said Bruce Shook, Intact Vascular’s president and CEO. “Steve’s experience with creating and motivating high performance sales teams, coupled with his deep knowledge of the peripheral vascular market, will be tremendous assets to us as we move toward launch of our flagship product next year.”
 
Prior to joining Intact Vascular, MacKinnon was the vice president of U.S. Sales for Neuronetics, where he significantly expanded the sales team and product revenue, and helped take the company public. Prior to Neuronetics, Steve served as vice president of U.S. Sales for Access Closure and was instrumental in its successful merger with Cardinal Health. He also held multiple sales positions with Fox Hollow Technologies prior to its sale to eV3.
 
“Intact Vascular represents an exciting opportunity to bring high-value innovations to peripheral vascular patients,” said Steve MacKinnon. “I look forward to building a world class sales organization at Intact and to a very successful launch of the Tack Endovascular System.”
 
Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack Endovascular System is designed to improve peripheral balloon angioplasty results in the treatment of peripheral arterial disease. Pre-loaded with six self-expanding nitinol devices for above-the-knee (ATK) interventions, the Tack Endovascular System can be deployed to treat multiple dissections using a single catheter and leaving behind less than 70 percent less metal than stents.1 Additionally, the Tack Endovascular System offers low radial force, designed to promote healing, improve outcomes and preserve future treatment options for PAD and critical limb ischemia (CLI) patients.
 
References
1. Bosiers M, Scheinert D, Hendricks JMH et al. Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplasty. J Vasc Surg 2016;64:109-16. [views] => 0 [published] => 1 [status] => 3 [priority] => 0 [publish_date] => 2018-12-17 08:58:00 [updated_at] => 2018-12-17 09:11:31 [last_updated_author] => 142087 [uploaded_by] => 142087 [user_role_id] => 0 [custom_fields] => [] [custom_fields_old] => [splitcontent] => 1 [content_url] => [related_content_ids] => ["303180","289765","289756","290022","289745","289790","289757","302111","299797","301733","289746","300701","299793","297829","289796","299952","289761","302321"] [is_show_company_name] => [created_at] => 2019-04-09 04:36:23 ) ) [relatedSearches] => Array ( [0] => Taxonomy Object ( [className] => Taxonomy [id] => 64850 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [taxonomy_tag] => electrophysiology ) [1] => Taxonomy Object ( [className] => Taxonomy [id] => 24551 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [taxonomy_tag] => Manufacturing ) [2] => Taxonomy Object ( [className] => Taxonomy [id] => 64227 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [taxonomy_tag] => company ) [3] => Taxonomy Object ( [className] => Taxonomy [id] => 58484 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [taxonomy_tag] => tubing ) ) [contentTaxonomy_knowledge-center] => Array ( [0] => Taxonomy Object ( [className] => Taxonomy [id] => 7975 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [content_taxonomy_id] => 6489667 [slug] => materials [child_of] => 8021 [ignore_flag] => 0 [up3_tag] => [up2_tag] => Knowledge Center [up1_tag] => Supply Chain [taxonomy_tag] => Materials [up3_id] => [up2_id] => 7963 [up1_id] => 8021 [taxonomy_id] => 7975 [depth] => 2 ) [1] => Taxonomy Object ( [className] => Taxonomy [id] => 7984 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [content_taxonomy_id] => 6489668 [slug] => tubing-and-extrusion [child_of] => 8021 [ignore_flag] => 0 [up3_tag] => [up2_tag] => Knowledge Center [up1_tag] => Supply Chain [taxonomy_tag] => Tubing & Extrusion [up3_id] => [up2_id] => 7963 [up1_id] => 8021 [taxonomy_id] => 7984 [depth] => 2 ) ) [formattedTitle] => Confluent Medical Technologies Launches Nitinol Tubing Center Of Excellence [taxonomy_keywords] => Array ( [0] => Taxonomy Object ( [className] => Taxonomy [id] => 24551 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => Manufacturing [slug] => manufacturing [child_of] => 24495 ) [1] => Taxonomy Object ( [className] => Taxonomy [id] => 24555 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => medical device companies [slug] => medical-device-companies [child_of] => 24495 ) [2] => Taxonomy Object ( [className] => Taxonomy [id] => 24563 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => Medical Devices [slug] => medical-devices [child_of] => 24495 ) [3] => Taxonomy Object ( [className] => Taxonomy [id] => 50352 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => medical device [slug] => medical-device [child_of] => 24495 ) [4] => Taxonomy Object ( [className] => Taxonomy [id] => 56704 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => implants [slug] => implants [child_of] => 24495 ) [5] => Taxonomy Object ( [className] => Taxonomy [id] => 57635 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => stents [slug] => stents [child_of] => 24495 ) [6] => Taxonomy Object ( [className] => Taxonomy [id] => 57855 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => heart [slug] => heart [child_of] => 24495 ) [7] => Taxonomy Object ( [className] => Taxonomy [id] => 57973 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => machining [slug] => machining [child_of] => 24495 ) [8] => Taxonomy Object ( [className] => Taxonomy [id] => 57991 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => implantable [slug] => implantable [child_of] => 24495 ) [9] => Taxonomy Object ( [className] => Taxonomy [id] => 57998 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => quality [slug] => quality [child_of] => 24495 ) [10] => Taxonomy Object ( [className] => Taxonomy [id] => 58484 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => tubing [slug] => tubing [child_of] => 24495 ) [11] => Taxonomy Object ( [className] => Taxonomy [id] => 58571 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => valve [slug] => valve [child_of] => 24495 ) [12] => Taxonomy Object ( [className] => Taxonomy [id] => 59080 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => development [slug] => development [child_of] => 24495 ) [13] => Taxonomy Object ( [className] => Taxonomy [id] => 61179 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => acquisition [slug] => acquisition [child_of] => 24495 ) [14] => Taxonomy Object ( [className] => Taxonomy [id] => 61847 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => costa rica [slug] => costa-rica [child_of] => 24495 ) [15] => Taxonomy Object ( [className] => Taxonomy [id] => 63660 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => medical [slug] => medical [child_of] => 24495 ) [16] => Taxonomy Object ( [className] => Taxonomy [id] => 63679 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => manufacturer [slug] => manufacturer [child_of] => 24495 ) [17] => Taxonomy Object ( [className] => Taxonomy [id] => 63698 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => track [slug] => track [child_of] => 24495 ) [18] => Taxonomy Object ( [className] => Taxonomy [id] => 64227 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => company [slug] => company [child_of] => 24495 ) [19] => Taxonomy Object ( [className] => Taxonomy [id] => 64229 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => technologies [slug] => technologies [child_of] => 24495 ) [20] => Taxonomy Object ( [className] => Taxonomy [id] => 64278 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => durability [slug] => durability [child_of] => 24495 ) [21] => Taxonomy Object ( [className] => Taxonomy [id] => 64675 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => market [slug] => market [child_of] => 24495 ) [22] => Taxonomy Object ( [className] => Taxonomy [id] => 64850 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => electrophysiology [slug] => electrophysiology [child_of] => 24495 ) [23] => Taxonomy Object ( [className] => Taxonomy [id] => 65816 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => ul [slug] => ul [child_of] => 24495 ) [24] => Taxonomy Object ( [className] => Taxonomy [id] => 66967 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => biomedical [slug] => biomedical [child_of] => 24495 ) [25] => Taxonomy Object ( [className] => Taxonomy [id] => 68024 [pageNumber] => [offset] => [totalPages] => [last_query] => [last_sql] => [show_errors] => 1 [databaseServer] => Array ( [key] => master [host] => 172.24.16.232 [user] => rodpub_beta [pass] => MvQQzhse92k58yA [db] => rodpub_beta ) [tableName] => taxonomy [tag] => confluent medical technologies [slug] => confluent-medical-technologies [child_of] => 24495 ) ) )